This information is for educational purposes only. Always consult a healthcare professional. Learn more

Cp2D

Prescription

Brand names: CP2D

Dosage Form
Injection
Route
INTRAVENOUS
Manufacturer
GVS TM INC

About This Medication

Description section ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION (CP2D), 250 mL 0455A-00 Description

Active Ingredients

Ingredient Strength
Dextrose, Unspecified Form -

Warnings & Precautions

Frequently Asked Questions

Warnings and precautions Warnings Not for direct intravenous infusion. Single-use container – discard unused portion. (do not reuse) Do not use unless the solution is clear and no leaks are detected. Precautions Use only with automated red-cell apheresis devices and follow the Operator’s Manual. Refer to the package insert for complete instructions. Storage/handling: Store at 25 °C/77 °F, avoid excessive heat, protect from freezing. Pouch is a moisture barrier; handle to maintain package integrity. Warnings and precautions

Cp2D is a prescription medication. You will need a valid prescription from a licensed healthcare provider.

Similar Injection Products

Browse all Injection products →

References & Data Sources

  • DailyMed — Cp2D drug label (National Library of Medicine)
  • openFDA — Cp2D label data (U.S. Food & Drug Administration)
  • NDC Directory — Cp2D (FDA National Drug Code)

Medical Disclaimer

The information on this page is intended for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment.

Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication.

Data sources: DailyMed (NLM), openFDA, MFDS

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.